Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 52.89
-1.45 (-2.67%)
At close: Jun 20, 2025, 2:57 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Recombinant Protein | 456.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Recombinant Protein Growth | 15.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibodies, Kits and Other Reagent | 60.81M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibodies, Kits and Other Reagent Growth | 5.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Detection Service | 15.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Detection Service Growth | 4.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 10.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 38.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-New Coronavirus Anti-epidemic Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-New Coronavirus Anti-epidemic Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Coronavirus Anti-epidemic Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Coronavirus Anti-epidemic Products - Recombinant Protein | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Coronavirus Anti-epidemic Products - Antibody | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Coronavirus Anti-epidemic Products - Reagent Test Kit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 10.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 38.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 358.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 21.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 185.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 3.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|